US Patent Issued to SPINALCYTE on June 9 for "Fibroblast and fibroblast-immunocyte combinations for treatment of subconcussive- and concussive-associated neurological damage" (California Inventor)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,648,968, issued on June 9, was assigned to SPINALCYTE LLC (Houston).

"Fibroblast and fibroblast-immunocyte combinations for treatment of subconcussive- and concussive-associated neurological damage" was invented by Thomas Ichim (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Embodiments of the disclosure include treatments of subconcussive and/or concussive brain damage by administering fibroblasts and/or fibroblasts cultured with one or more types of immunocytes. In one specific embodiment fibroblasts are cultured with monocytes in the presence of patient-specific T cells, and subsequently the T cells are re-administered into the patient. In o...